Algert Global LLC Takes Position in Teleflex Incorporated $TFX

Key Points

• Algert Global LLC has acquired a new position in Teleflex Incorporated, purchasing 26,220 shares valued at approximately $3.62 million, representing 0.06% of the company.
• Several institutional investors, including T. Rowe Price and Dimensional Fund Advisors, have significantly increased their holdings in Teleflex, indicating strong institutional interest in the stock.
• Teleflex's latest quarterly earnings exceeded expectations, reporting $3.73 EPS and $780.90 million in revenue, accompanied by a declared quarterly dividend of $0.34 per share.

Algert Global LLC acquired a new position in shares of Teleflex Incorporated (NYSE:TFX - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 26,220 shares of the medical technology company's stock, valued at approximately $3,623,000. Algert Global LLC owned about 0.06% of Teleflex as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also made changes to their positions in the company. MassMutual Private Wealth & Trust FSB raised its holdings in Teleflex by 103.1% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company's stock valued at $27,000 after acquiring an additional 100 shares in the last quarter. Banque Cantonale Vaudoise bought a new stake in shares of Teleflex in the 1st quarter valued at approximately $27,000. Costello Asset Management INC bought a new stake in Teleflex during the 1st quarter worth approximately $28,000. Whipplewood Advisors LLC grew its position in Teleflex by 7,700.0% during the 1st quarter. Whipplewood Advisors LLC now owns 234 shares of the medical technology company's stock worth $32,000 after acquiring an additional 231 shares during the last quarter. Finally, Allworth Financial LP grew its position in Teleflex by 504.8% during the 1st quarter. Allworth Financial LP now owns 254 shares of the medical technology company's stock worth $34,000 after acquiring an additional 212 shares during the last quarter. Institutional investors and hedge funds own 95.62% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms have issued reports on TFX. Truist Financial reduced their price objective on Teleflex from $140.00 to $137.00 and set a "hold" rating on the stock in a report on Monday, May 5th. Mizuho upped their price objective on Teleflex from $130.00 to $135.00 and gave the stock a "neutral" rating in a report on Friday, August 1st. Wells Fargo & Company reduced their price objective on Teleflex from $137.00 to $131.00 and set an "equal weight" rating on the stock in a report on Friday, August 1st. Morgan Stanley reduced their price objective on Teleflex from $191.00 to $173.00 and set an "overweight" rating on the stock in a report on Monday, May 5th. Finally, Wall Street Zen raised Teleflex from a "hold" rating to a "strong-buy" rating in a report on Saturday, August 2nd. One equities research analyst has rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, Teleflex has an average rating of "Hold" and a consensus price target of $141.57.

Teleflex Trading Down 1.3%

Shares of TFX stock traded down $1.6790 during trading hours on Monday, reaching $127.7410. The company had a trading volume of 478,982 shares, compared to its average volume of 568,303. The company has a 50 day moving average of $118.28 and a 200 day moving average of $130.03. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.41 and a quick ratio of 1.44. The firm has a market cap of $5.64 billion, a price-to-earnings ratio of 30.06, a P/E/G ratio of 1.80 and a beta of 1.08. Teleflex Incorporated has a 1-year low of $108.90 and a 1-year high of $249.90.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The medical technology company reported $3.73 earnings per share for the quarter, beating analysts' consensus estimates of $3.36 by $0.37. The company had revenue of $780.90 million for the quarter, compared to the consensus estimate of $771.53 million. Teleflex had a return on equity of 15.08% and a net margin of 6.31%.The firm's quarterly revenue was up 4.2% on a year-over-year basis. During the same quarter in the prior year, the business posted $3.42 EPS. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. On average, equities research analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, September 15th. Investors of record on Friday, August 15th will be paid a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend is Friday, August 15th. Teleflex's dividend payout ratio (DPR) is presently 32.00%.

Insider Buying and Selling at Teleflex

In other Teleflex news, Director Gretchen R. Haggerty acquired 500 shares of the company's stock in a transaction that occurred on Wednesday, August 6th. The shares were acquired at an average price of $114.75 per share, with a total value of $57,375.00. Following the purchase, the director owned 6,305 shares of the company's stock, valued at $723,498.75. This represents a 8.61% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Liam Kelly bought 1,500 shares of the stock in a transaction on Tuesday, August 5th. The shares were purchased at an average price of $115.07 per share, with a total value of $172,605.00. Following the acquisition, the chief executive officer owned 45,267 shares in the company, valued at approximately $5,208,873.69. This represents a 3.43% increase in their position. The disclosure for this purchase can be found here. Insiders have acquired a total of 5,500 shares of company stock worth $633,590 in the last three months. 1.40% of the stock is owned by insiders.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.